Invesco
ARVN icon

Invesco’s Arvinas ARVN Stock Holding History

Invesco’s Portfolio ARVN Stock Details ARVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.36M Buy
316,654
+14,554
+5% +$180K ﹤0.01% 2335
2025
Q4 		$3.58M Buy
302,100
+64,044
+27% +$699K ﹤0.01% 2391
2025
Q3 		$2.03M Buy
238,056
+75,128
+46% +$570K ﹤0.01% 2610
2025
Q2 		$1.2M Buy
162,928
+81,181
+99% +$598K ﹤0.01% 2778
2025
Q1 		$574K Buy
81,747
+44,493
+119% +$697K ﹤0.01% 3097
2024
Q4 		$714K Buy
37,254
+581
+2% +$14.1K ﹤0.01% 3060
2024
Q3 		$903K Buy
36,673
+544
+2% +$14.2K ﹤0.01% 2949
2024
Q2 		$962K Buy
36,129
+1,523
+4% +$48.5K ﹤0.01% 2948
2024
Q1 		$1.43M Sell
34,606
-137,831
-80% -$6.02M ﹤0.01% 2829
2023
Q4 		$7.1M Buy
172,437
+126,835
+278% +$2.96M ﹤0.01% 2041
2023
Q3 		$896K Sell
45,602
-143,232
-76% -$3.51M ﹤0.01% 2918
2023
Q2 		$4.69M Sell
188,834
-40,318
-18% -$1.04M ﹤0.01% 2276
2023
Q1 		$6.26M Sell
229,152
-522,927
-70% -$16.5M ﹤0.01% 2108
2022
Q4 		$25.7M Sell
752,079
-12,842
-2% -$540K 0.01% 1245
2022
Q3 		$34M Buy
764,921
+204,045
+36% +$9.91M 0.01% 1049
2022
Q2 		$23.6M Sell
560,876
-53,722
-9% -$2.7M 0.01% 1270
2022
Q1 		$41.4M Buy
614,598
+70,801
+13% +$4.83M 0.01% 1082
2021
Q4 		$44.7M Buy
543,797
+61,087
+13% +$4.97M 0.01% 1092
2021
Q3 		$39.7M Buy
482,710
+340,242
+239% +$30.1M 0.01% 1141
2021
Q2 		$11M Buy
142,468
+133,146
+1,428% +$9.24M ﹤0.01% 1991
2021
Q1 		$617K Sell
9,322
-125,832
-93% -$9.63M ﹤0.01% 3258
2020
Q4 		$11.5M Buy
+135,154
New +$4.66M ﹤0.01% 1725
2020
Q3 		– Sell
-17,218
Closed -$578K – 3622
2020
Q2 		$578K Sell
17,218
-86,174
-83% -$3.66M ﹤0.01% 3064
2020
Q1 		$4.17M Buy
103,392
+26,721
+35% +$1.25M ﹤0.01% 1991
2019
Q4 		$3.15M Buy
+76,671
New +$2.24M ﹤0.01% 2434

Other funds holding ARVN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Invesco's ARVN Position: Q1 2026 in Review

Invesco increased its Arvinas (ARVN) stake by 4.8% in Q1 2026, buying an estimated $180K and bringing the position to 316,654 shares worth $3.36M. The position accounts for ﹤0.01% of the portfolio, ranked #2335.

Invesco first reported a position in ARVN in Q4 2019 and has held it in 25 quarters since. The position peaked at $44.7M in Q4 2021. 206 funds tracked by Wall St. Rank hold ARVN as of Q1 2026.

  • Invesco held 316,654 shares of Arvinas worth $3.36M as of Q1 2026.
  • Invesco bought 14,554 Arvinas shares in Q1 2026, an estimated $180K.
  • Arvinas made up ﹤0.01% of Invesco's portfolio in Q1 2026, its #2335 holding.
  • Invesco first reported a position in Arvinas in Q4 2019 and has held it in 25 quarters since.
  • Invesco's Arvinas position peaked at $44.7M in Q4 2021.
  • 206 funds tracked by Wall St. Rank held Arvinas as of Q1 2026.

Based on Invesco's 13F filing for Q1 2026, filed 12 May 2026.